| 000 | 02408ntm a2200337 i 4500 | ||
|---|---|---|---|
| 003 | MY-KuUP | ||
| 005 | 20260120155014.0 | ||
| 006 | t||||fs|||| 000 0 | ||
| 007 | ta | ||
| 008 | 260120t20252025my a|||fs|||| 000 0 eng d | ||
| 020 |
_aTHE0010289 (Local) _qHardback |
||
| 040 |
_aUMPSA _beng _cUMPSA _erda |
||
| 090 | _aFIST .C43 2025 r Bc. | ||
| 100 | 0 |
_aChao Miao Sheng _eauthor. |
|
| 245 | 1 | 0 |
_aEvaluation of the effects of kyllinga nemoralis cream in rat model of skin-induced allergy / _cChao Miao Sheng |
| 264 | 1 |
_aKuantan, Pahang : _bUMPSA, _c2025 |
|
| 264 | 4 | _c© 2025 | |
| 300 |
_axii, 69 pages : _billustrations ; |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 347 |
_2rda _atext file _bPDF |
||
| 500 | _aFaculty of Industrial Sciences and Technology | ||
| 502 | _aFinal Year Report (Bachelor of Applied Science in Industrial Biotechnology) -- Universiti Malaysia Pahang Al-Sultan Abdullah - 2025 | ||
| 504 | _aInclude bibliographical reference | ||
| 520 | 3 | _aSkin allergies, including atopic dermatitis (AD), are chronic inflammatory conditions that significantly affect quality of life and pose treatment challenges. This study investigates the therapeutic potential of Kyllinga nemoralis extract, known for its anti-inflammatory properties, in a rat model of skin-induced allergy. AD-like lesions were induced using 2,4-dinitrochlorobenzene (DNCB), followed by treatment with K. nemoralis cream at 5% and 10% concentrations. Key metrics, including skin scaling scores, body weight, food intake, and organ weights (liver and kidney), were evaluated. The 5 % cream significantly reduced skin scaling scores from 2.80 ± 0.37 to 1.00 ± 0.00 after 7 days, outperforming the 10% formulation. Liver weights remained unaffected, while untreated lesions showed significantly different in kidney weight, suggesting potential adverse effects of untreated AD. The results, comparable to 1% hydrocortisone cream, indicate K. nemoralis as a promising natural treatment for inflammatory skin conditions. Further studies, including human trials and pharmacokinetic analyses, are recommended to confirm its clinical applicability | |
| 610 | 2 | 0 |
_aFaculty of Industrial Sciences and Technology _xDissertations |
| 650 | 0 |
_aUniversities and colleges _xDissertations |
|
| 650 | 0 |
_aFinal Year Report _xDissertations |
|
| 942 |
_2lcc _cPSM |
||
| 999 |
_c103896 _d103902 |
||